Spiber Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.94M

  • Investors
  • 1

Spiber General Information

Description

Developer of a biotechnology platform designed to offer recombinant technology for producing advanced biomaterials. The company's technology offers proprietary recombinant spider silk proteins that are difficult to produce and are ideal for cell culturing, enabling medical professionals to use spider protein application areas in medical technology.

Contact Information

Website
www.spiber.se
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • AlbaNova University Center
  • 106 91 Stockholm
  • Sweden
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • AlbaNova University Center
  • 106 91 Stockholm
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spiber Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 31-Dec-2024 $5.94M Completed Startup
3. Later Stage VC 31-Dec-2019 Completed Generating Revenue
2. Later Stage VC 31-Dec-2016 $2.17M $2.17M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Spiber’s complete valuation and funding history, request access »

Spiber Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary 67,500 $45.51 $45.51 1x $45.51 6.21%
Ordinary 62,500 $29.08 $29.08 1x $29.08 5.75%
To view Spiber’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Spiber Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology platform designed to offer recombinant technology for producing advanced biomaterials. The
Biotechnology
Stockholm, Sweden
10 As of 2026

East Troy, WI
 

Berkeley, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Spiber Competitors (3)

One of Spiber’s 3 competitors is CaP Biomaterials, a Corporate Backed or Acquired company based in East Troy, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CaP Biomaterials Corporate Backed or Acquired East Troy, WI
Berkeley Advanced Biomaterials Corporate Backed or Acquired Berkeley, CA
3DBioFibR Venture Capital-Backed Halifax, Canada
You’re viewing 3 of 3 competitors. Get the full list »

Spiber Patents

  • 163

    Total Documents Applications and Grants

  • Total Patents Families

  • 107

    Granted

  • 9

    Pending

  • Expiring in next 12 mo

Spiber Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4569086-A1 3d islet formation from endocrine progenitor cells Pending 08-Aug-2022
US-20260049285-A1 3d islet formation from endocrine progenitor cells Pending 08-Aug-2022
WO-2024033300-A1 3d islet formation from endocrine progenitor cells Inactive 08-Aug-2022
EP-4569085-A1 In vitro derivation of pancreatic islets from human pluripotent stem cells Pending 08-Aug-2022
US-20260055373-A1 In vitro derivation of pancreatic islets from human pluripotent stem cells Pending 08-Aug-2022 C12N5/0676
To view Spiber’s complete patent history, request access »

Spiber Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Spiber Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alsteron Family Office Minority
To view Spiber’s complete investors history, request access »

Ready to get started?

Request a free trial

Spiber FAQs

  • When was Spiber founded?

    Spiber was founded in 2008.

  • Where is Spiber headquartered?

    Spiber is headquartered in Stockholm, Sweden.

  • What is the size of Spiber?

    Spiber has 10 total employees.

  • What industry is Spiber in?

    Spiber’s primary industry is Biotechnology.

  • Is Spiber a private or public company?

    Spiber is a Private company.

  • What is the current valuation of Spiber?

    The current valuation of Spiber is .

  • What is Spiber’s current revenue?

    The current revenue for Spiber is .

  • How much funding has Spiber raised over time?

    Spiber has raised $11.7M.

  • Who are Spiber’s investors?

    Alsteron has invested in Spiber.

  • Who are Spiber’s competitors?

    CaP Biomaterials, Berkeley Advanced Biomaterials, and 3DBioFibR are competitors of Spiber.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process